Clinical Trial Update: NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High-risk Genetic Alterations

View source ↗

Summary

This clinical trial update describes a non-interventional study to evaluate the effectiveness of TDC in patients with metastatic non-small cell lung cancer with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TDC

Snippet

Sponsor: AstraZeneca | Conditions: Non-squamous Metastatic Non-Small-Cell Lung Carcinoma | Status: RECRUITING